Solventum (SOLV): analysis and statistics
Return, volatility, Sharpe ratio and risk for Solventum, a component of the S&P 500 in the Health Care sector. Data as of 2026-09-13.
| Last close price | $87.45 |
| Sector (GICS) | Health Care |
| Annualized return (0.2 yr) | +92.12% |
| Total return over period | +10.35% |
| Annualized volatility | 32.26% |
| Period volatility | 12.53% |
| Sharpe ratio | 2.73 |
| Sortino ratio | 4.70 |
| Max drawdown | -6.31% |
| CVaR 95% (avg. loss, worst 5% of days) | -5.16% |
| Correlation with the S&P 500 | 0.04 |
| Period range | $77.24 – $92.44 |
| Trading days analyzed | 38 |
Over the last 0.2 years, Solventum (SOLV) has posted an annualized return of +92.12% with annual volatility of 32.26%, a Sharpe ratio of 2.73. Its worst stretch (max drawdown from a peak) was -6.31%. Its correlation with the S&P 500 is 0.04, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how SOLV would fit inside an optimized portfolio alongside other stocks, try the optimizer.
Optimize a portfolio with SOLV →
Other Health Care stocks
Is it part of the S&P 500?
Yes, Solventum (SOLV) is of the S&P 500.
What is the Sharpe ratio? · How to optimize an investment portfolio